Submitted by Anonymous (not verified) on 11 May 2026 - 9:01 Orphan designation: selinexor Treatment of myelofibrosis, 11/10/2022 Positive Link: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2705Source: What's new